Research and Development

Boehringer Ingelheim is to enter phase III studies with a candidate to treat a subset of patients with non-small cell …

The Institute of Clinical Research (ICR) is to hold its next annual spring conference and exhibition on 19-20 April at …

Covance's late-stage development services unit helped the contract research organisation to a 7% increase in second quarter net revenues, ahead …

Roche's rising star Avastin has won US approval to treat the most common type of kidney cancer, the latest in …

 UCB has opened its new biologics research centre in the UK, marking an investment of £25 million for the growing …

US pharmaceutical firm Mylan has promoted chief operating officer Heather Bresch to the post of president as it rides a …

Merck Serono is to appeal against the European rejection of Erbitux as a lung cancer treatment.Erbitux has been rejected as …

CRO Synexus has doubled its head office capacity as it continues to grow across the UK, Central and Eastern Europe, …

The first crop of second-quarter figures from the contract research sector reveals a mixed bag, with PPD and Icon affected …

 The Niagara Falls are one of the wonders of the natural world, and every year millions of visitors from around …

US pharmaceutical services firm AAIPharma has sold its drug development division to a private equity firm in another example of …

Bristol-Myers Squibb is to spend $2.1 billion in buying Medarex, the human antibody drug discovery specialists. Princeton-based Medarex is best …